Period Ending | Mar 30, 2013 | Mar 30, 2012 | Mar 30, 2011 |
---|
Total Revenue
|
4,643,000
|
4,814,000
|
4,429,000
| Cost of Revenue | 638,000 | 643,000 | 581,000 | |
Gross Profit
|
4,005,000
|
4,171,000
|
3,848,000
| |
|
Operating Expenses |
|
Research Development | 490,000 | 510,000 | 471,000 |
|
Selling General and Administrative | 1,676,000 | 1,871,000 | 1,744,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 477,000 | 401,000 | 379,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
1,362,000
|
1,389,000
|
1,254,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,362,000 | 1,389,000 | 1,254,000 |
|
Interest Expense | 44,000 | 35,000 | 45,000 |
|
Income Before Tax | 1,318,000 | 1,354,000 | 1,209,000 |
|
Income Tax Expense | 363,000 | 416,000 | 386,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 955,000 | 938,000 | 823,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
| 13,000 | 4,000 |
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
955,000
|
951,000
|
827,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
955,000
|
951,000
|
827,000
|
|